UnitedHealth Group (NYSE:UNH) is scheduled to be issuing its quarterly earnings data before the market opens on Tuesday, April 16th. Analysts expect the company to announce earnings of $3.58 per share for the quarter. UnitedHealth Group has set its FY 2019 guidance at $14.40-14.70 EPS and its FY19 guidance at $14.40-14.70 EPS.Parties that are interested in participating in the company’s conference call can do so using this link .
UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, January 15th. The healthcare conglomerate reported $3.28 earnings per share for the quarter, beating analysts’ consensus estimates of $3.20 by $0.08. UnitedHealth Group had a net margin of 5.30% and a return on equity of 24.38%. The business had revenue of $58.42 billion during the quarter, compared to the consensus estimate of $58.01 billion. During the same quarter in the prior year, the firm earned $2.59 EPS. The company’s revenue for the quarter was up 12.2% compared to the same quarter last year. On average, analysts expect UnitedHealth Group to post $15 EPS for the current fiscal year and $17 EPS for the next fiscal year.
Get UnitedHealth Group alerts: Shares of NYSE:UNH opened at $223.22 on Friday. The company has a quick ratio of 0.73, a current ratio of 0.73 and a debt-to-equity ratio of 0.64. UnitedHealth Group has a fifty-two week low of $220.77 and a fifty-two week high of $287.94. The stock has a market cap of $225.89 billion, a P/E ratio of 17.33, a price-to-earnings-growth ratio of 1.20 and a beta of 0.79.
The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Investors of record on Monday, March 11th were given a dividend of $0.90 per share. This represents a $3.60 dividend on an annualized basis and a dividend yield of 1.61%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio is presently 27.95%.
UNH has been the subject of a number of recent research reports. Zacks Investment Research downgraded shares of UnitedHealth Group from a “buy” rating to a “hold” rating in a research report on Tuesday, December 18th. Oppenheimer boosted their price objective on shares of UnitedHealth Group from $300.00 to $305.00 and gave the company an “outperform” rating in a research report on Wednesday, January 16th. Cleveland Research reaffirmed a “buy” rating on shares of UnitedHealth Group in a research report on Friday, January 11th. Argus boosted their price objective on shares of UnitedHealth Group from $285.00 to $295.00 and gave the company a “buy” rating in a research report on Monday, December 17th. Finally, Credit Suisse Group reaffirmed a “buy” rating and set a $310.00 price objective on shares of UnitedHealth Group in a research report on Friday, February 8th. Three analysts have rated the stock with a hold rating and twenty have issued a buy rating to the company. The stock has an average rating of “Buy” and a consensus target price of $297.80.
In other UnitedHealth Group news, Director Gail R. Wilensky sold 2,930 shares of the company’s stock in a transaction dated Thursday, March 14th. The shares were sold at an average price of $253.39, for a total value of $742,432.70. Following the completion of the transaction, the director now owns 64,726 shares in the company, valued at approximately $16,400,921.14. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website . Also, Director William C. Ballard, Jr. sold 5,000 shares of the company’s stock in a transaction dated Tuesday, January 22nd. The stock was sold at an average price of $266.61, for a total transaction of $1,333,050.00. Following the completion of the transaction, the director now owns 77,702 shares of the company’s stock, valued at approximately $20,716,130.22. The disclosure for this sale can be found here . In the last 90 days, insiders sold 32,930 shares of company stock valued at $8,495,383. 0.87% of the stock is owned by insiders.
TRADEMARK VIOLATION WARNING: This piece of content was originally published by Stock Observer and is the sole property of of Stock Observer. If you are accessing this piece of content on another site, it was stolen and republished in violation of international copyright and trademark law. The correct version of this piece of content can be accessed at https://www.thestockobserver.com/2019/04/14/unitedhealth-group-unh-set-to-announce-quarterly-earnings-on-tuesday.html.
UnitedHealth Group Company Profile
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. It operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health and well-being services to individuals age 50 and older, addressing their needs for preventive and acute health care services, as well as services dealing with chronic disease and other specialized issues for older individuals; and Medicaid plans, Children's Health Insurance Program, and health care programs; and health and dental benefits.
Featured Story: What are gap-up stocks?
UnitedHealth Group UnitedHealth Group